Qingdao Haier Biomedical

What Qingdao Haier Biomedical does

Qingdao Haier Biomedical Co., Ltd. (青岛海尔生物医疗股份有限公司, SSE: 688139) is a publicly listed Chinese life science and medical equipment company founded in 2005 and headquartered in Qingdao, operating as a subsidiary of the Haier Group conglomerate. The company designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain management equipment, biosafety products, and laboratory automation tools. Its core technology stack combines ultra-low temperature refrigeration, IoT connectivity, AI-powered monitoring and computer vision, and domain-specific AI models such as the Hailinglong Lingyan large language model — China's first sample-library domain-specific LLM. The company serves five primary verticals — universities/research institutes, hospitals, pharmaceutical companies, blood/plasma stations, and public health agencies — through direct enterprise sales, a global network of over 800 dealers across 160 countries, and overseas R&D centers in the UK, Italy, and Japan supporting localized product development.

The company's revenue model is anchored in hardware sales of life science laboratory equipment, complemented by an expanding AI-powered applications and solutions revenue stream (15% of 2025 revenue, up 2.5 percentage points from 2024). Full-year 2025 revenue reached 2.33 billion yuan (USD 340.77 million), a 17.9% year-over-year increase, with international revenue at 840 million yuan representing a record 36% of total. New business segments contributed 48.5% of total revenue, signaling successful business mix evolution from legacy cold chain hardware to integrated life science scenarios. The company is executing a three-year '543' strategic plan targeting over 50% overseas revenue, 30% AI-related revenue, and over 40% revenue from acquired businesses by 2028, supported by active geographic expansion (Q1 2026 growth of 50%+ in Germany, Australia, and Canada and over 100% in Eastern Europe, South Asia, and Brazil), ongoing product launches (HAB80-60KA/60KB, DWL368BPST, Super Energy series, AutoLab Mind, Hailinglong Lingyan LLM), and inorganic moves including the December 2023 acquisition of Guangzhou Kangsheng Biotechnology and EU MDR certification for the Plasma Apheresis System XJ-III.

Name

Qingdao Haier Biomedical

Legal name

青岛海尔生物医疗股份有限公司

Website

https://haierbiomedical.com

Company type

Public

Founded year

2005

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Qingdao Haier Biomedical (SSE: 688139) designs and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain equipment, and AI-integrated life science laboratory products. The company serves pharmaceutical companies, hospitals, research institutes, biobanks, and public health agencies across 160 countries.

Ownership category

akta.pro rank

Product category

Life Science Laboratory Equipment

NAICS

Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing (333415), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585), Refrigeration & Service Industry Machinery (3580), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cold Chain & Temperature-Controlled Storage Equipment (IMAHAKAJ)

akta.pro secondary industries

Biologics, Vaccines & Ultra-Low Temperature (ULT) Storage (TLALABAG), Medical Devices & Diagnostics Temperature-Controlled Storage (TLALABAH), Medical & Clinical Specimen Frozen Storage (Labs, Biobanks) (TLALACAE)

Keywords

• Biomedical cold storage
• Ultra-low temperature freezers
• Automated biobank systems
• IoT cold chain monitoring
• Life science laboratory equipment

Headquarters

HQ city

Qingdao

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Life Science Laboratory Equipment Sales: Haier Biomedical generates revenue primarily through the sale of life science laboratory equipment including ultra-low temperature freezers, automated sample storage systems, biobank solutions, blood management systems, and pharmaceutical storage solutions. The company achieved full-year 2025 revenue of 2.33 billion yuan (USD 340.77 million) with international revenue of 840 million yuan representing 36% of total revenue.
2. AI-Powered Applications and Solutions: AI-powered applications and software solutions contributed 15% of total revenue in 2025, up 2.5 percentage points from 2024, including automated biobank management, intelligent blood management, and AI-integrated medical products. New business segments contributed 48.5% of total revenue.
3. Sustainability and Digital Transformation Services: The company provides digital, global, and platform-oriented transformation services aligned with its LIFE sustainability framework, positioning itself as an integrated life science tools and intelligent productivity platform provider rather than a pure hardware vendor.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Qingdao Haier Biomedical designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, smart hospital medication and blood management systems, and AI-integrated medical products for pharmaceutical companies, research institutions, hospitals, blood stations, and public health agencies. The company also provides reagents, consumables, biosafety equipment, scientific instruments, and digital transformation services, and is transitioning from hardware supplier to integrated life science tools and intelligent productivity platform provider through its IoT and AI capabilities.

Product overview

Qingdao Haier Biomedical (海尔生物医疗, stock code 688139.SH) is a life science and medical innovation company offering a comprehensive platform-plus-modules product architecture. The portfolio centers on ultra-low temperature storage systems (HAB80-60KA/60KB automated storage, DWL368BPST compact freezer, Ultra Energy series, Super Energy series) complemented by an extensive ecosystem of laboratory equipment including pre-processing systems, biosafety equipment, scientific instruments, and smart hospital solutions. The company is undergoing strategic transformation from hardware supplier to integrated life science tools provider, with AI+ capabilities now integrated across product lines through solutions like the Hailinglong Lingyan Large Model (sample library AI), AutoLab Mind platform, AI+ automated cell culture solutions, cytotoxic drug dispensing robots, and intelligent blood management systems. Core solutions span biobank management, smart vaccination, digital hospital medication management, and laboratory automation.

Differentiator

Problem solved

Functional benefit

Brands

• 盈康一生 (Yingkang Yisheng): Related brand/platform under the Haier healthcare ecosystem umbrella.

Products and services

• HAB80-60KA/60KB Automated Ultra-Low Temperature Sample Storage System Automated ultra-low temperature sample storage system for biobank applications at -80°C, with AI-powered monitoring, scalable modular architecture for 50,000 to 200,000+ samples, and low-carbon design targeting European biobank customers.
• DWL368BPST Compact Ultra-Low Temperature Freezer Space-efficient ultra-low temperature freezer engineered for Japanese laboratories, featuring 26% lower energy consumption, ±2°C temperature uniformity, and 45% faster temperature recovery compared to conventional models.
• Plasma Apheresis System XJ-III Plasma apheresis system with EU MDR certification for blood component collection and processing in clinical settings across the European Union.
• Hailer Vaccine Smart Safety Solution (海乐苗智慧安全接种)

Quantifiable outcome

• 26% lower energy consumption and 45% faster temperature recovery compared to conventional models for DWL368BPST ultra-low temperature freezer
• +6 more outcomes

Named customers13 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core.

• Università degli Studi di PadovacoreStrategic or Co-development Partner · 25 June 2026Deep academic partnership with Università degli Studi di Padova as part of Haier Biomedical's strategy to deepen localization investments and build academic partnerships supporting the 'In Europe, for Europe' localization strategy and European market development.
• Alibaba Cloud (阿里云)coreTechnology or Integration · 10 April 2026AI for Science strategic ecosystem partnership for cloud computing and AI infrastructure support, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
• Zhongke Zidong Taichu (中科紫东太初)coreTechnology or Integration · 10 April 2026AI for Science strategic ecosystem partnership for AI model development, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
• Aobo Robotics (遨博（北京）智能)coreTechnology or Integration · 10 April 2026AI for Science strategic ecosystem partnership for robotics integration, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
• Shandong University of Science and Technology (山东科技大学)coreStrategic or Co-development Partner · 10 April 2026AI for Science strategic ecosystem partnership for research collaboration and talent development, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
• China Information Industry Association Embodied AI Specialized Committee (中国信息协会具身智能专委会)coreStrategic or Co-development Partner · 10 April 2026AI for Science strategic ecosystem partnership for embodied AI standards and industry collaboration, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
• 37 European Regional Partners (23 Countries)coreChannel Partner/ Reseller/ Distributor · 11 March 2026European Partner Summit in Rome with 37 regional partners from 23 European countries, outlining the long-term European commitment and unveiling expanded laboratory solutions portfolio under the 'In Europe, for Europe' localization strategy. Rollout of automated biobank solutions and intelligent blood management systems through these channel partners.
• GAVI, the Vaccine AlliancecoreStrategic or Co-development Partner · 1 January 2025Partnership with GAVI for global immunization support and health equity, documented in the 2025 sustainability report under the LIFE framework aligned with UN's 17 Sustainable Development Goals. Includes charitable donations of 1.406 million yuan.

Scale indicators16 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Helmer Scientific: US-based manufacturer of medical-grade cold storage, particularly blood bank refrigerators and plasma freezers. Direct overlap with Haier Biomedical's hospital, blood station, and clinical laboratory segments in North America.
• PHC Holdings (formerly Panasonic Healthcare): Direct competitor in biomedical cold storage, including ultra-low temperature freezers and pharmaceutical-grade refrigeration under PHCbi. Operates globally with strong European and US presence, making it a primary head-to-head rival for Haier Biomedical's ULT and biobank systems.
• Stirling Ultracold: US manufacturer of ultra-low temperature freezers with a focus on energy-efficient Stirling engine technology. Competes directly in the ULT freezer category, including for biobank and pharmaceutical storage applications.
• Azenta Life Sciences (formerly Brooks Life Sciences): Provider of sample storage, automated biobanking, and cold chain solutions. Recently combined with B Medical Systems, making it a direct competitor in automated sample management and biorepository solutions where Haier Biomedical's HAB80-60KA/60KB platform competes.
• Eppendorf: German lab equipment manufacturer with overlapping product lines in temperature-controlled storage, sample handling, and cell culture. Strong in European pharmaceutical and academic research markets where Haier Biomedical is actively expanding.
• B Medical Systems: Specializes in medical cold chain including vaccine cold boxes, plasma freezers, and ULT storage. Recently combined with Azenta's life sciences business, directly competing with Haier Biomedical in blood bank, vaccine, and biobank cold chain.

Regional players

• Labconco: US-based manufacturer of laboratory equipment including biosafety cabinets and cold storage. Has partial product overlap with Haier Biomedical's biosafety and laboratory equipment lines, primarily in the North American market.

Broad incumbents

• Thermo Fisher Scientific: Global leader in life sciences with a deep portfolio including ultra-low temperature freezers, sample storage, and biobank solutions. Competes with Haier Biomedical across pharma and research customers worldwide but at vastly greater scale and with broader adjacent offerings.
• Mindray: Shenzhen-based Chinese medical device major with extensive hospital and IVD product lines. Competes with Haier Biomedical in the smart hospital medication management and biomedical equipment segments within China and emerging markets.

Others

• Haier Smart Home: Sister listed entity under the same Haier Group parent, focused on consumer appliances. While not a direct competitor, it provides relevant peer context on the parent conglomerate's global brand and distribution scale leveraged by Haier Biomedical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qingdao Haier Biomedical